LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, announced today that Manish Singh, Ph.D., the company’s President and CEO, will present during the PrecisionIR Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference. Dr. Singh’s corporate presentation will begin at 9:00 A.M. eastern time on Wednesday, October 13, and can be accessed at http://www.investorcalendar.com/IC/ClientPage.asp?ID=160525. Audio of the webcast and the accompanying slide presentation will be available via the aforementioned link for one year.
